Compositions and methods for protein detection
Labeled surrogate peptides in mass spectrometry assays address the limitations of immunoassays by enabling selective detection and quantification of target proteins in complex biological samples, improving accuracy and sensitivity in protein analysis.
Patent Information
- Application Number
- JP2021564422
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-04-29
- Filing Date
- 2020-04-21
- Publication Date
- 2024-11-21
- Estimated Expiration
- 2040-04-21
Smart Images

Figure 0007588090000001 
Figure 0007588090000002 
Figure 0007588090000003
Abstract
Description
[Technical field]
[0001] Reference to Electronically Submitted Sequence Listing An official copy of the Sequence Listing has been submitted electronically via EFS-Web as an ASCII format Sequence Listing with the file name "81875-WO-REG-ORG-P-1_SeqList.txt" having a size of 1 kilobyte, created on April 20, 2020, and filed contemporaneously herewith. The Sequence Listing contained in this ASCII format document is a part of this specification and is incorporated herein by reference in its entirety.
[0002] The present invention relates generally to the use of mass spectrometry to selectively detect, quantitate, and characterize target proteins in complex biological samples. [Background technology]
[0003] Immunoassays, such as enzyme-linked immunosorbent assays (ELISAs), are currently the preferred method in the agricultural industry for the detection and quantification of plant endogenous proteins or proteins introduced by genetic modification of plants. A critical component of an immunoassay is an antibody with specificity for the target protein (antigen). Immunoassays can be very specific, and samples often require only simple preparation prior to analysis. Furthermore, immunoassays can be used qualitatively or quantitatively over a wide range of concentrations. Typically, immunoassays require a separate test for each protein of interest. Antibodies can be polyclonal, produced in animals, or monoclonal, produced by cell culture. In essence, a mixture of polyclonal antibodies will have multiple recognition epitopes, which can increase sensitivity but also reduce specificity, as the number of different antibody paratopes present increases the likelihood of sequence and structural homology with other proteins. Monoclonal antibodies offer several advantages over polyclonal antibodies, as they exhibit a consistent affinity and specificity for a single epitope or antigenic determinant, and can be produced in large quantities. However, for more demanding applications such as selective detection and quantification of a single protein in a complex mixture of similar transgenic or endogenous proteins, all antibodies have inherent properties that limit their use. In addition, both polyclonal and monoclonal antibodies may require additional purification steps to increase sensitivity and reduce background in the assay. Furthermore, ELISA systems may not be able to detect subtle changes in the target protein that may have a dramatic effect on its physical and biological properties. For example, antibodies may not recognize certain forms of proteins or peptides that are altered by post-translational modifications such as phosphorylation or glycosylation, or that are conformationally masked or modified by partial degradation. Identification of such modifications is crucial, since changes in the physical and biological properties of these proteins may play an important role in their enzymatic, clinical or other biological activities.Such variations can limit the reliability and usefulness of ELISA-based quantification methods.
[0004] Currently, effective identification and / or quantification of proteins in crop plants relies on the accuracy of immunoassays. The construction of a successful immunoassay depends on the specific characteristics of the antigen used to construct the antibody, namely, the size, hydrophobicity and tertiary structure of the antigen, and the quality and accuracy of the antibody. The specificity of the antibody must be carefully examined to elucidate any cross-reactivity with similar substances that may result in false positive results. A current problem in the industry is that many of the antibodies in commercially available test kits do not distinguish between similar proteins of various proteins in different crop plants.
[0005] Mass spectrometry (MS) offers an alternative platform that overcomes many limitations of ELISA for protein analysis. The field of MS-based analysis has brought about important advances in targeted protein analysis, such as multiple reaction monitoring (MRM) by electrospray liquid chromatography coupled with tandem mass spectrometry (LC-MS / MS). The underlying concept is that a protein can be quantified by measuring its specific constituent peptides (surrogate peptides) after protein digestion. Data collection of only selected peptides allows for higher accuracy, sensitivity, and throughput measurements. Protein quantification by MRM-based measurement of surrogate peptides is the fastest growing application of MS in protein analysis. MRM-based protein assays offer two compelling advantages over immuno-based assays, the first being the ability to systematically construct specific assays for essentially any protein without the use of antibodies. The second advantage is that targeted MS assays can perform multiplex analysis of many peptides in a single analysis. Furthermore, MRM is a direct analysis, whereas immuno-based assays are indirect. Immuno-based assays rely on a binding assay consisting of a linked reagent that can be immobilized on a solid phase along with a detection reagent that specifically binds to it, and uses an enzyme to generate a suitable quantifiable signal.
[0006] Therefore, there is a continuing need to identify surrogate peptides that have all the necessary biochemical properties to function in MRM-based assays and have the additional property of being absolutely specific for target proteins whose amino acid sequences may largely overlap, i.e., one or more of the transition states of the surrogate peptides can clearly distinguish two closely related target proteins across multiple complex matrices without interference. Such selective surrogate peptides and their transition states should be able to distinguish target proteins that are similar to each other or to transgenic proteins in transgenic crop plants. Summary of the Invention [Problem to be solved by the invention]
[0007] The present invention provides labeled surrogate peptides and their respective transition ions that are useful for selectively detecting or quantifying target proteins in complex biological matrices using mass spectrometry. The present invention further provides methods and systems for selectively detecting or quantifying target HPPD proteins in complex biological matrices using the labeled surrogate peptides and transition ions. [Means for solving the problem]
[0008] In one aspect of the invention, internal standard peptide markers are designed through empirical and computational digestion analysis and are either chemically synthesized with heavy amino acid residues or genetically synthesized by expressing synthetic genes in the presence of stable isotope-labeled amino acids or metabolic intermediates. In certain embodiments, the internal standards can be individually characterized by mass spectrometry (MS), including tandem mass spectrometry (MS / MS), more specifically, liquid chromatography-linked tandem mass spectrometry (LC-MS / MS). After characterization, preselected peptide parameters can be collected, such as the monoisotopic mass of each peptide, its surrogate charge state, surrogate m / z value, m / z transition ion, and ion type of each transition ion. Other considerations include optimizing peptide size, avoiding post-translational modifications, avoiding process-induced modifications, and avoiding high rates of protease cleavage errors.
[0009] In one aspect, the invention provides a labeled surrogate peptide that functions to selectively detect or quantify p-hydroxyphenylpyruvate dioxygenase (HPPD) protein in a mixture of proteins in one or more biological samples from one or more crop plants in a mass spectrometry assay, the surrogate peptide comprising a label and an amino acid sequence selected from the group consisting of GNFSELFK (SEQ ID NO:1) and GNFSQLFK (SEQ ID NO:2). In some embodiments, the labeled surrogate peptide is labeled by incorporation of a stable isotope labeled (SIL) amino acid. In other embodiments, the SIL amino acid is lysine, isoleucine, valine, or arginine. In other embodiments, the plant is barley, rice, soybean, wheat, oat, or corn. In yet other embodiments, the crop plant is barley, rice, soybean, wheat, or rice, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:1. In yet other embodiments, the crop plant is corn, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:2.
[0010] In one aspect, the present invention provides an assay cassette comprising at least two labeled surrogate peptides of claim 1.
[0011] In one aspect, the present invention provides a method for simultaneously detecting or quantifying one or more target HPPD proteins in a complex biological sample from a crop plant containing a mixture of target and non-target proteins, the method comprising the steps of: (a) obtaining a biological sample from the crop plant; (b) extracting proteins from the biological sample to result in an extract comprising a mixture of proteins; (c) reducing the amount of insoluble proteins in the extract of step b to result in an extract of concentrated soluble proteins; (d) digesting the soluble proteins in the extract of step c to result in an extract comprising peptide fragments, the peptide fragments comprising at least one surrogate peptide specific for the target protein; (e) enriching the peptide fragments in the extract of step d; and (f) adding one or more labeled surrogate peptides of the present invention, wherein each labeled surrogate peptide is a nucleotide sequence specific for the target protein. The method includes the steps of: (g) enriching the surrogate peptides and the labeled surrogate peptides by reducing the amount of non-surrogate peptides in the mixture; (h) separating the peptide fragment mixture from step g by liquid chromatography; (i) analyzing the peptide fragment mixture from step h by mass spectrometry, wherein detection of transition ion fragments of the labeled surrogate peptides indicates the presence of the target protein from which the surrogate peptides are derived; and, optionally, (j) calculating the amount of the target protein in the biological sample by comparing the mass spectrometry signals generated from the transition ion fragments of step i and the mass spectrometry signals generated by the transitions. In some embodiments, the crop plant is barley, rice, soybean, wheat, or rice, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:1. In other embodiments, the crop plant is maize, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:2. In other embodiments, the peptides are labeled by incorporation of stable isotope labeled (SIL) amino acids.In yet other embodiments, the SIL amino acid is lysine, isoleucine, valine, or arginine.
[0012] Many different combinations of surrogate peptides can be simultaneously monitored and quantified by MRM assays using one or more of the specific surrogate peptides from the HPPD protein of the present invention, thus providing a means to measure the total amount of each of these proteins in a given protein preparation obtained from a biological sample by mass spectrometry. These peptides have numerous applications in combination with MRM-based assays, including quantitative peptide / protein analysis to determine expression levels at different developmental stages of crop plants, to determine expression levels in different crop plant tissues and organs, including but not limited to leaf tissue, seeds and grains, pollen and root tissues, to determine potential exposure levels for regulatory risk assessment, to determine different levels of proteins in food processing, comparison, and generation studies. In the broadest sense, these unique surrogate peptides for the seven proteins can be used in combination with MRM assays for numerous applications, including agricultural applications, bioequivalence testing, biomarkers, diagnostics, discovery, food, environmental, and therapeutic monitoring in all types of biological and non-biological matrices. In some embodiments of the present invention, an assay cassette is provided comprising one or more labeled surrogate peptides of the present invention, which allows for simultaneous and selective detection or quantification of any one or more target proteins of the present invention.
[0013] The present invention also provides a method for selectively detecting or quantifying target HPPD proteins in complex biological matrices, such as biological samples from crop plants, comprising the steps of obtaining a sample from a crop plant, e.g., a sample from leaves, seeds or grains, pollen or roots, extracting proteins from the plant sample, enriching the target protein pool by reducing the amount of insoluble proteins in the extract, digesting soluble proteins in the extract with a selected enzyme, e.g., trypsin, to result in an extract comprising peptide fragments, the peptide fragments comprising at least one surrogate peptide specific for each target protein, and adding an assay cassette of SIL peptides that specifically detect the target protein, wherein each labeled surrogate peptide has the same amino acid sequence as each surrogate peptide of the target protein, and adding The method includes the steps of: enriching the surrogate peptides and the labeled surrogate peptides by reducing the amount of non-surrogate peptides in the mixture; separating the peptide fragment mixture using liquid chromatography; and analyzing the peptide fragment mixture using mass spectrometry, where detection of transition ion fragments of the labeled surrogate peptides indicates the presence of the target protein from which the surrogate peptides are derived; and, optionally, calculating the amount of the target protein in the biological sample by comparing the mass spectrometry signals generated from the transition ion fragments and the mass spectrometry signals generated by the transition ions of the labeled surrogate peptides. Each SIL surrogate peptide derived from the protein of the present invention has a unique transition ion during a mass spectrometry-based multiple reaction monitoring (MRM) assay. Thus, these peptides may generate selective MS ions due to slight changes in collision energy resulting in different degrees of ionization. For example, a triple quadrupole MS can be used to generate peptide-specific high m / z ions.As a result, the methods of the invention provide a selective advantage, reducing endogenous background compared to the use of lower m / z, intense ion markers that may be known in the art.
[0014] The present invention further provides a system for high-throughput detection or quantification of a target protein, comprising a cassette of pre-designed labeled surrogate peptides specific for the target protein and one or more mass spectrometers.
[0015] Various objects, features, aspects and advantages of the present invention will become more apparent from the following detailed description of preferred embodiments of the invention, along with the accompanying drawings and sequence listing. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] A brief description of the sequence SEQ ID NO:1 is the amino acid sequence of a stable isotope labeled surrogate peptide for selective detection and quantification of HPPD protein in barley, rice, soybean, wheat and oat.
[0017] SEQ ID NO:2 is the amino acid sequence of a stable isotope-labeled surrogate peptide for selective detection and quantification of HPPD protein in maize.
[0018] Detailed Description This description is not intended to be a detailed list of all of the various ways in which the invention may be implemented or all of the features that may be added to the invention. For example, features described with respect to one embodiment may be incorporated into other embodiments, and features described with respect to a particular embodiment may be omitted from that embodiment. Thus, the present invention contemplates that in some embodiments of the invention, any feature or combination of features described herein may be eliminated or omitted. Moreover, numerous variations and additions to the various embodiments suggested herein will be apparent to those skilled in the art in light of this disclosure and do not depart from the invention. Thus, the following description is intended to describe some particular embodiments of the invention, and is not intended to exhaustively specify all of the permutations, combinations, and variations thereof.
[0019] Unless otherwise defined, all scientific and technical terms used herein have the same meaning as commonly understood by those skilled in the art to which the present invention belongs. The terminology used in the description of the present invention herein is intended to describe only specific embodiments and is not intended to limit the present invention. It should also be understood that the terminology used herein is intended to describe only specific embodiments and is not intended to limit the scope of the present invention.General references relevant to the present invention include Alwine et al. (1977) Proc. Nat. Acad. Sci. 74:5350-54; Baldwin (2004) Mol. Cell. Proteomics 3(1):1-9; Can and Annan (1997) Overview of peptide and protein analysis by mass spectrometry. In: Current Protocols in Molecular Biology, Ausubel, et al., eds. New York: Wiley, p. 10.21.1-10.21.27; Chang et al. (2000) Plant Physiol. 122(2):295-317; Domon and Aebersold (2006) Science 312(5771):212-17; Nain et al. (2005) Plant Mol.Biol.Rep.23:59-65;Patterson (1998) Protein identification and characterization by mass spectrometry.In:Current Protocols in Molecular Biology, edited by Ausubel, et al. New York: Wiley, p.10.22.1-10.22.24;Paterson and Aebersold (1995)Electrophoresis 16:1791-1814;Rajagopal and Ahern(2001)Science 294(5551):2571-73;Sesikeran and Vasanthi(2008)Asia Pac.J.Clin.Nutr.17 Suppl.1:241-44;and Toplak et al.(2004)Plant Contains Mol.Biol.Rep.22:237-50.
[0020] definition As used in this specification and claims, the singular forms "a," "an," and "the" can refer to one or to more than one. Thus, for example, reference to a "plant" can refer to a single plant or to multiple plants.
[0021] As used herein, "and / or" refers to and includes any and all possible combinations of one or more of the associated listed items, as well as the absence of a combination when interpreted as the alternative "or."
[0022] The term "about" is used herein to mean approximately, roughly, roughly, or in the region. When the term "about" is used in conjunction with a range of numerical values, the range is modified by extending the boundaries above and below the numerical values stated. In general, the term "about" is used herein to modify numerical values above and below the stated value by a variance of 20 percent, preferably 10 percent upwards or downwards (higher or lower). With respect to temperature, the term "about" means ±1°C, preferably ±0.5°C. When the term "about" is used in the context of the present invention (e.g., in conjunction with a temperature or molecular weight value), the exact value (i.e., without "about") is preferred.
[0023] The terms "comprises" and / or "comprising" as used herein specify the presence of stated features, integers, steps, operations, elements, and / or components, but do not exclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and / or groups thereof.
[0024] As used herein, the transitional phrase "consisting essentially of" (and grammatical variations) means that the claims should be interpreted to include the specific materials or steps recited in the claim and "that do not materially alter the basic and novel characteristics" of the claimed invention. Thus, the term "consisting essentially of" when used in the claims of the present invention is not intended to be interpreted as the equivalent of "comprising."
[0025] As used herein, the term transgenic "event" refers to a recombinant plant produced by transformation and regeneration of a single plant cell with heterologous DNA, e.g., an expression cassette containing a gene of interest. The term "event" refers to the original transformant and / or the progeny of the transformant that contain the heterologous DNA. The term "event" also refers to the progeny resulting from sexual outcrossing between a transformant and another corn line. Even after repeated backcrossing to the recurrent parent, the inserted and flanking DNA from the transformed parent are present in the progeny of the cross at the same chromosomal location. Usually, transformation of plant tissue produces multiple events, each of which represents the insertion of a DNA construct into a different location in the genome of the plant cell. A particular event is selected based on the expression of the transgene or other desired characteristics.Non-limiting examples of such transgenic events of the present invention include "event Bt11" (also referred to as "Bt11 event" or simply "Bt11"), which contains cry1Ab and pat genes, and is described in U.S. Pat. No. 6,114,608; "event 5307" (also referred to as "5307 event" or simply "5307"), which contains eCry3.1Ab and PMI genes, and is described in U.S. Pat. No. 8,466,346; "event MIR6" (also referred to as "event MIR6" or simply "5307"), which contains mCry3A and PMI genes, and is described in U.S. Pat. No. 7,361,813; No. 8,232,456 , containing the Vip3A and PMI genes, “event MIR162” (also referred to as “event MIR162” or simply “MIR162”), “event GA21” (also referred to as “GA21 event” or simply “GA21”), containing the alpha-amylase 797E and PMI genes and described in U.S. Pat. No. 7,635,799 , containing the alpha-amylase 797E and PMI genes and described in U.S. Pat. No. 7,635,799 , and containing the alpha-amylase 797E and PMI genes and described in U.S. Pat. No. 6,713,259; "event MON810" (also referred to as "MON810 event" or simply "MON810"), which contains Cry1Ab and is described in U.S. Pat. No. 6,713,259; "event MON89034" (also referred to as "MON89034 event" or simply "MON89034"), which contains Cry1A.105 and Cry2Ab genes and is described in U.S. Pat. No. 8,062,840; "event MON89034" (also referred to as "MON89034 event" or simply "MON89034"), which contains Cry1F and PAT genes and is described in U.S. Pat. No. 7,288,643; No. 7,323,556, which contains Cry1F, Cry34 / Cry35 and PAT genes, and "event DAS59122" (also referred to as "DAS59122 event" or simply "DAS59122"), and "event DP4114" (also referred to as "DP4114 event" or simply "DP4114") ...DAS59122 event" or simply "DAS59122") (also referred to as "DAS59122 event" or simply "DAS59122") (also referred to as "DAS59122 event" or simply "DAS59122") (also referred to as "DAS59122 event" or simply "DAS59
[0026] The term "isolated" nucleic acid molecule, polynucleotide, or toxin is a nucleic acid molecule, polynucleotide, or toxic protein that is no longer in its natural environment. The isolated nucleic acid molecule, polynucleotide, or toxin of the invention may be present in a purified form or may be present in a recombinant host, such as a transgenic bacterial cell or a transgenic plant.
[0027] As used herein, the general term "mass spectrometry" refers to any suitable mass spectrometry method, device or arrangement, including, for example, electrospray ionization (ESI), matrix-assisted laser desorption / ionization (MALDI) MS, MALDI-time of flight (TOF) MS, atmospheric pressure (AP) MALDI MS, vacuum MALDI MS, tandem MS, or any combination thereof. Mass spectrometry devices measure the molecular mass of a molecule (as a function of the molecule's mass-to-charge ratio) by measuring the flight path of the molecule through a series of magnetic and electric fields. Mass-to-charge ratio is a physical quantity that is widely used in the electrodynamics of charged particles. The mass-to-charge ratio of a particular peptide can be calculated a priori by one of skill in the art. Two particles with different mass-to-charge ratios will not travel the same path in a vacuum when exposed to the same electric and magnetic fields. The present invention includes, inter alia, the use of high performance liquid chromatography (HPLC) followed by peptide tandem MS analysis. In "tandem mass spectrometry," surrogate peptides are selected in an MS instrument, and the surrogate peptides can subsequently be fragmented to produce one or more "transition ions," which are analyzed (detected and / or quantified) in a second MS procedure.
[0028] Detailed reviews of mass spectrometry methodologies and instrumentation can be found in the following references, which are incorporated herein by reference: Can and Annan (1997) Overview of peptide and protein analysis by mass spectrometry. In: Current Protocols in Molecular Biology, edited by Ausubel, et al. New York: Wiley, p. 10.21.1-10.21.27; Paterson and Aebersold (1995) Electrophoresis 16:1791-1814; Patterson (1998) Protein identification and characterization by mass spectrometry. In: Current Protocols in Molecular Biology, edited by Ausubel, et al. New York: Wiley, p. 10.22.1-10.22.24; and Domon and Aebersold (2006) Science 312(5771):212-17.
[0029] Peptides are short polymers formed from the linkage of alpha-amino acids in a defined order, and can be generated by digestion of polypeptides, such as proteins, with proteases.
[0030] A "plant" is any plant at any stage of development, particularly a seed plant.
[0031] A "plant cell" is the structural and physiological unit of a plant, including the protoplast and the cell wall. A plant cell may be in the form of an isolated single cell or a cultured cell, or may be part of a more highly organized unit, such as, for example, a plant tissue, a plant organ, or a whole plant.
[0032] "Plant cell culture" refers to cultures of plant units at various developmental stages, such as, for example, protoplasts, cell culture cells, cells in plant tissue, pollen, pollen tubes, ovules, embryo sacs, zygotes and embryos.
[0033] "Plant material" refers to leaves, stems, roots, flowers or flower parts, fruits, pollen, egg cells, zygotes, seeds, cuttings, cell or tissue cultures, or any other part or product of a plant.
[0034] A "plant organ" is a clearly and visibly structured and differentiated part of a plant, such as a root, stem, leaf, bud, or embryo.
[0035] As used herein, "plant tissue" refers to a group of plant cells organized into a structural and functional unit. Any tissue of a plant in planta or culture is included. The term includes, but is not limited to, whole plants, plant organs, plant seeds, tissue cultures, and any group of plant cells organized into a structural and / or functional unit. Use of this term with or without any particular type of plant tissue described above or otherwise encompassed by this definition is not intended to exclude any other type of plant tissue.
[0036] As used herein, the term "surrogate peptide" refers to a peptide derived from a target protein by proteolytic digestion, e.g., tryptic digestion, and functions in a mass spectrometry assay to generate one or more transition ions that, in combination with the surrogate peptide, differentially detect and / or quantify the target protein when the target protein is in the presence of one or more other proteins and / or transgenic proteins in a complex biological matrix, such as a sample from a crop plant, and do not detect and / or quantify one or more other proteins or transgenic proteins in the biological matrix. A "surrogate peptide" may also be referred to as a "signature peptide" of a target protein. For example, the HPPD surrogate peptide of the present invention generates one or more transition ions that, in combination with the HPPD-surrogate peptide, differentially detect and / or quantify a target HPPD protein in a complex biological matrix when the HPPD protein is in the presence of one or more non-HPPD proteins. According to embodiments of the present invention, two or more labeled surrogate peptides of the present invention may be used simultaneously in a mass spectrometry assay to detect and / or quantify two or more target proteins in a complex biological matrix.
[0037] A "labeled surrogate peptide" is a non-naturally occurring surrogate peptide that is labeled to facilitate detection of the surrogate peptide in a mass spectrometry assay. For example, the label can be a stable isotope labeled amino acid (SIL), such as lysine, isoleucine, valine, or arginine. Thus, a SIL-labeled surrogate peptide has the same amino acid sequence as an unlabeled surrogate peptide, except that one or more of the amino acids of the surrogate peptide are labeled with a heavy isotope. For example, as described herein, the surrogate peptide GNFSELFK (SEQ ID NO: 1) is labeled with a heavy lysine (K) and can be referred to as GNFSELFK[C13N15-K], and so forth.
[0038] As used herein, the term "stacked" or "stacking" refers to the presence of multiple heterologous polynucleotides or transgenic proteins or transgenic events incorporated into the genome of a plant.
[0039] As used herein, "target protein" refers to a protein that is intended to be selectively detected and / or quantified by a labeled surrogate peptide when the target protein is in a complex biological matrix.
[0040] Nucleotides are referred to herein by the following standard abbreviations: adenine (A), cytosine (C), thymine (T), and guanine (G). Amino acids are similarly designated by the following standard abbreviations: alanine (Ala; A), arginine (Arg; R), asparagine (Asn; N), aspartic acid (Asp; D), cysteine (Cys; C), glutamine (Gln; Q), glutamic acid (Glu; E), glycine (Gly; G), histidine (His; H), isoleucine (Ile; 1), leucine (Leu; L), lysine (Lys; K), methionine (Met; M), phenylalanine (Phe; F), proline (Pro; P), serine (Ser; S), threonine (Thr; T), tryptophan (Trp; W), tyrosine (Tyr; Y), and valine (Val; V).
[0041] The present invention encompasses compositions, methods and systems useful for performing mass spectrometry for the differential detection and / or quantification of one or more target HPPD proteins in complex biological samples derived from crop plants that contain a mixture of target and non-target proteins, each of which may differentially affect the outcome of a mass spectrometry assay, such as biological samples from leaves, stems, roots, pollen and seeds of one or more crop plants.
[0042] The accuracy of target protein quantification by mass spectrometry multiple reaction monitoring assay (MRM) is entirely dependent on the selection of appropriate surrogate peptides and the ability of the surrogate peptide / transition ion combination to distinguish the target proteins. Many different combinations of the surrogate peptides of the present invention can be simultaneously monitored and quantified by MRM assay using one or more of the specific peptides from HPPD proteins, thus providing a means to identify and quantify each of the target HPPD proteins in a given biological sample by mass spectrometry. The available surrogate peptides that make up the cassette can be analyzed alone or in any combination in a single MRM assay, or can be analyzed in multiple MRM assays.
[0043] The surrogate peptides of the present invention have numerous applications, including quantitative peptide / protein analysis in conjunction with MRM-based assays to determine expression levels at different developmental stages, to determine potential exposure levels for environmental risk assessment, to determine different levels of target proteins in food processing, to determine expression levels in comparative studies, and to compare expression levels in generational studies. In the broadest sense, these unique surrogate peptides of target proteins can be used in conjunction with MRM assays to monitor or quantify herbicide resistance traits, which can be either crop plants or transgenic events within a specific tissue (i.e., leaf, root, grain, pollen), or breeding stacks of multiple transgenic events.
[0044] MRM-based assays can quantify or measure either the relative or absolute levels of specific surrogate peptides from HPPD proteins. The relative quantitative levels of these proteins can be determined by MRM assays by comparing their signature peak areas with each other. The relative levels of individual HPPD surrogate peptides can be quantified from different samples or tissue types. In general, the relative quantitative levels are determined by comparing peptide abundances in MRM measurements using stable isotope-labeled (SIL) synthetic peptide analogs as internal standards for each target surrogate peptide. Contrary to what is commonly taught in the art, SIL peptides are [ 13 C6 15 N2] lysine or [ 13 C6 15N4] are labeled by incorporation of arginine, but can also contain other amino acids such as isoleucine and valine. The SIL standards must be of high purity and quantitatively standardized by amino acid analysis. Contrary to what is typically taught in the art, the SILs of the present invention are added to the sample immediately after protein digestion, thus serving to correct the subsequent analytical steps. The SILs co-elute with the unlabeled surrogate peptides in liquid chromatographic separations and show identical MS / MS fragmentation patterns, differing only in mass due to isotopic labeling. This resulting mass shift in both the labeled surrogate peptides and the product ions allows the mass spectrometer to distinguish between unlabeled and labeled peptides. Since complex peptide digests often contain multiple sets of co-eluting transitions that may be mistaken for target peptides, the co-elution of isotopically labeled standards identifies the correct signal and provides the best protection from false positive quantification. Since spiked SIL standards of known concentration are added to each sample, the quantitative relative amounts of each of the corresponding surrogate peptides from different target proteins can be determined for the HPPD protein. Relative quantification of individual peptide(s) can be performed relative to the amount of another peptide(s), within or between samples, so that it is possible to determine the relative amounts of peptides present by determining whether the peak areas are related to each other within a biological sample. Relative quantitative data obtained from individual signature peak areas between different samples is usually normalized to the amount of protein analyzed per sample. Relative quantification can be performed across multiple peptides from multiple proteins simultaneously in a single sample and / or across multiple samples to gain further insight into the relative protein amount of one peptide / protein with respect to other peptides / proteins.
[0045] Absolute quantitative levels for HPPD can be determined by MRM-based assays by comparing the signature peak areas of individual surrogate peptides from the corresponding proteins in one biological sample to known amounts of one or more internal standards in the sample, which can be accomplished by spiking known concentrations of these proteins in a negative control matrix that does not contain the target protein. Multiple reaction monitoring (MRM) assays include weighing non-target samples with precise spiked concentrations of target protein; extracting and homogenizing the samples in lysis buffer; centrifuging the samples to separate soluble and insoluble proteins to concentrate and reduce extraction complexity; digesting the soluble protein samples with trypsin (tissue or biological samples can be treated with one or more proteases, including but not limited to trypsin, chymotrypsin, pepsin, endoproteases Asp-N and Lys-C, for a period of time sufficient to digest the sample); centrifuging the samples and adding a fixed concentration of SIL peptide (SIL is used as an index in absolute quantification); desalting by solid phase extraction utilizing cation exchange to minimize matrix effects or interferences and reduce ion suppression; and analyzing the samples by liquid chromatography coupled to tandem mass spectrometry. Typically, an ion trap mass spectrometer or another form of mass spectrometer capable of performing comprehensive profiling to identify as many peptides as possible from a single complex protein / peptide lysate is usually performed for the analysis. Although MRM-based assays can be constructed and performed in any type of mass spectrometer, the most favorable instrument platform for MRM assays is often considered to be a triple quadrupole instrument platform. The surrogate peptides of interest and SILs specific to the seven proteins are measured by LC-MS / MS. The peak area ratio (peak area of the surrogate peptide / peak area of the corresponding SIL peptide) is determined for each peptide of interest. The concentrations of the seven proteins of interest are calculated back from the calibration curve using the peak area ratios.Absolute quantification can be performed across multiple peptides (allowing quantitative determination of multiple proteins simultaneously in a single sample) and / or across multiple samples to gain insight into absolute protein abundance in individual biological samples or large sample sets.
[0046] In some embodiments, the invention encompasses a labeled surrogate peptide that functions to selectively detect or quantify p-hydroxyphenylpyruvate dioxygenase (HPPD) protein in a mixture of proteins in one or more biological samples from one or more crop plants in a mass spectrometry assay, the surrogate peptide comprising a label and an amino acid sequence selected from the group consisting of GNFSELFK (SEQ ID NO:1) and GNFSQLFK (SEQ ID NO:2). In some aspects, the labeled surrogate peptide is labeled by incorporation of a stable isotope labeled (SIL) amino acid. In other aspects, the SIL amino acid is lysine, isoleucine, valine, or arginine. In other aspects, the crop plant is barley, rice, soybean, wheat, oat, or corn. In yet other aspects, the crop plant is barley, rice, soybean, wheat, or rice, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:1. In yet other aspects, the crop plant is corn, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:2.
[0047] In some embodiments, the invention encompasses an assay cassette comprising at least two labeled surrogate peptides comprising an amino acid sequence selected from the group consisting of GNFSELFK (SEQ ID NO:1) and GNFSQLFK (SEQ ID NO:2).
[0048] In some embodiments, the invention encompasses a method for simultaneously detecting or quantifying one or more target HPPD proteins in a complex biological sample from a crop plant containing a mixture of target and non-target proteins, the method comprising the steps of: (a) obtaining a biological sample from the crop plant; (b) extracting proteins from the biological sample to result in an extract comprising a mixture of proteins; (c) reducing the amount of insoluble proteins in the extract of step b to result in an extract of concentrated soluble proteins; (d) digesting the soluble proteins in the extract of step c to result in an extract comprising peptide fragments, the peptide fragments comprising at least one surrogate peptide specific for the target protein; (e) enriching the peptide fragments in the extract of step d; and (f) adding one or more labeled surrogate peptides of the invention, wherein each labeled surrogate peptide is a surrogate peptide of the invention. The method includes the steps of: (g) enriching the surrogate peptides and the labeled surrogate peptides by reducing the amount of non-surrogate peptides in the mixture; (h) separating the peptide fragment mixture from step g by liquid chromatography; (i) analyzing the peptide fragment mixture from step h by mass spectrometry, wherein detection of transition ion fragments of the labeled surrogate peptides indicates the presence of the target protein from which the surrogate peptides are derived; and, optionally, (j) calculating the amount of the target protein in the biological sample by comparing the mass spectrometry signals generated from the transition ion fragments of step i and the mass spectrometry signals generated by the transitions. In some embodiments, the crop plant is barley, rice, soybean, wheat, or rice, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:1. In other embodiments, the crop plant is maize, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:2. In other embodiments, the peptides are labeled by incorporation of stable isotope labeled (SIL) amino acids.In yet other aspects, the SIL amino acid is lysine, isoleucine, valine, or arginine.
[0049] Numerous references in the art, such as Mead et al. 2009. Mol. Cell. Proteomics 8:696-705 and U.S. Pat. No. 8,227,252, suggest many different methods to predict which surrogate peptides are best for any given target protein, and many references suggest shortcuts to quantify target proteins using mass spectrometry. However, reliance on such predictive methods and shortcuts can lead to confusing results, as unpredictable factors can interfere with mass spectrometry-based assays, thus causing loss of sensitivity and inaccurate quantification. At least one major factor is the biological matrix itself. For example, it is very unpredictable and difficult to identify a single transition ion from a surrogate peptide that can work equally well with biological samples from leaves, roots, pollen, and seeds from crop plants. Differences in the chemical composition, pH, or ionic strength of the matrix can affect proteolysis, peptide stability, aggregation, or ionization in the MS instrument. Therefore, identification and experimental testing of surrogate peptides and specific surrogate peptide / transition ion combinations across all relevant matrices, especially those of crop plants, is essential to overcome the unpredictable nature of such assays. The present invention uses a two-step approach in constructing a mass spectrometry assay for specifically detecting and / or quantifying a target protein, including 1) testing and selecting surrogate peptides from a pool of peptides derived from a proteolytically cleaved target protein, testing SIL surrogate peptide and transition ion peptide combinations, and selecting a combination that specifically detects and quantifies the target protein across all biological matrices, e.g., biological samples from leaves, roots, pollen, or seeds of crop plants, and 2) experimentally determining appropriate methods of sample preparation and mass spectrometer conditions that work for all surrogate peptides and surrogate peptide / transition ion combinations in all biological matrices, including leaves, roots, pollen, and seeds of crop plants, especially corn plants.
[0050] Thus, in some embodiments, the present invention encompasses a method for simultaneously detecting and / or quantifying one or more target proteins in a complex biological sample from a transgenic plant comprising a mixture of target transgenic and non-transgenic proteins, the method comprising the steps of: a) obtaining a biological sample from the transgenic plant; b) extracting proteins from the biological sample to result in an extract comprising a mixture of proteins; c) reducing the amount of non-transgenic insoluble proteins in the extract of step b to result in an extract of enriched soluble proteins; d) digesting the soluble proteins in the extract of step c to result in an extract comprising peptide fragments, the peptide fragments comprising at least one unlabeled surrogate peptide specific for each target protein; e) enriching the peptide fragments in the extract of step d; f) enriching one or more labeled surrogate peptides of the present invention. adding a peptide fragment mixture containing unlabeled surrogate peptides to a biological sample, each labeled surrogate peptide having the same amino acid sequence as a respective unlabeled surrogate peptide derived from the target protein, the number of labeled surrogate peptides added being equal to the number of target proteins in the mixture; g) enriching the unlabeled surrogate peptides and the labeled surrogate peptides by reducing the amount of non-surrogate peptides in the mixture; h) separating the peptide fragment mixture from step g by liquid chromatography; i) analyzing the peptide fragment mixture obtained from step h by mass spectrometry, wherein detection of transition ion fragments of the unlabeled surrogate peptides indicates the presence of the target protein from which the surrogate peptides are derived; and optionally j) calculating the amount of the target protein in the biological sample by comparing the mass spectrometry signals generated from the transition ion fragments of step i with the mass spectrometry signals generated by the transition ions of the labeled surrogate peptides.
[0051] The following specific examples are included to demonstrate preferred embodiments of the invention. It should be appreciated by those skilled in the art that the techniques disclosed in the following examples represent techniques discovered by the inventors to work well in the practice of the invention, and therefore may be considered to constitute preferred modes for its practice. However, those skilled in the art should, in light of this disclosure, appreciate that numerous changes can be made in the specific embodiments disclosed and still obtain similar or similar results without departing from the concept, spirit and scope of the invention. More specifically, it will be appreciated that certain agents that are both chemically and physiologically related may be substituted for the agents described herein while still achieving the same or similar results. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims. EXAMPLES
[0052] Although the invention has been described with respect to specific embodiments thereof, it will be understood that the device of the invention is capable of further modification. This patent application is intended to cover any variations, uses, or adaptations of the invention which generally follow the principles of the invention and which come within known or customary practice within the art to which the invention pertains, and which may be applied to the essential features set forth herein above, including such departures from the present disclosure as fall within the scope of the appended claims.
[0053] All publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
[0054] Example 1. Validation of Quantification of Endogenous p-Hydroxyphenylpyruvate Dioxygenase in Commodity Crop Commodities Using a Mass Spectrometric Assay The objective of this study was to validate a mass spectrometry (MS)-based method for quantifying p-hydroxyphenylpyruvate dioxygenase (HPPD) protein in various crops (barley, corn, rice, soybean, and wheat seeds, and barley, corn, oat, soybean, and wheat forage) using liquid chromatography coupled to tandem mass spectrometry (LC-MS / MS). Relative concentrations were determined using surrogate peptides specific to the HPPD protein. Prior to implementing the quantitative method in the study, the method was validated for the intended application in accordance with Good Laboratory Practice Standards (GLPS). Crop samples were used to evaluate method performance parameters, including specificity, linearity, limit of quantification, carryover, precision and accuracy, extraction efficiency, and stability.
[0055] The specificity assessment showed no significant interference with the retention times of unlabeled peptides (mean ratios of the two transitions differed less than 30.0% between blank and buffer) and stable isotope labeled (SIL) peptides (less than 5.0% of the SIL signal of QC0 (endogenous)) in any of the crop samples tested. All specificity parameters met the acceptance criteria.
[0056] The lower limit of quantification (LLOQ) of each signature peptide used as a surrogate for the target HPPD protein was determined as follows: 0.209 μg / g dry weight (DW) for barley seeds, 0.122 μg / g DW for corn seeds, 0.083 μg / g DW for rice seeds, 0.686 μg / g DW for soybean seeds, 0.301 μg / g DW for wheat seeds, 0.524 μg / g DW for barley feed, 0.326 μg / g DW for corn feed, 0.660 μg / g DW for oat feed, 1.001 μg / g DW for soybean feed, and 0.640 μg / g DW for wheat feed.
[0057] The quantitative ranges (LLOQ and upper limit of quantification (ULOQ)) of HPPD validated for each crop are summarized in Table 1.
[0058] [Table 1]
[0059] The intra- and inter-assay CVs were below 25.0% for the QC0 samples and below 20.0% for the quality control (QC) samples of three concentrations (low, medium and high), indicating good method precision. Similarly, the intra- and inter-assay bias% was within ±20.0% for the low, medium and high QC samples, indicating good method accuracy. Thus, all method precision and accuracy parameters met the acceptance criteria. The intra- and inter-assay precision and accuracy of the method are summarized in Table 2.
[0060] [Table 2]
[0061] A linear equation with a data weighting of 1 / x was used to represent the concentration / detector response relationship, and all of the established data were therefore found to be within the acceptance criteria and suitable for linearity evaluation.
[0062] The efficiency of the protein extraction method was 59.9% for barley seeds, 69.8% for corn seeds, 73.9% for rice seeds, 64.9% for soybean seeds, 54.3% for wheat seeds, 69.8% for barley feed, 76.3% for corn feed, 78.4% for oat feed, 65.4% for soybean feed, and 77.2% for wheat feed. The CVs for the first extraction round were lower than 20.0% for all crops except wheat seeds (27.5% CV). However, the precision and accuracy results (QC0) for wheat seeds from a single extraction demonstrate that a precision of 20.0% or less was achieved.
[0063] Processing stability (dried extract) was evaluated for 6 days at -20°C. The stability evaluation met the acceptance criteria. The CV was less than or equal to 25.0% and the % difference in peak area ratio between stability QC and Day 0 QC was within ±25.0% for all crops.
[0064] All performance parameters evaluated met the defined acceptance criteria, except for the final extraction % for barley and wheat seeds (8.2 and 6.2%, respectively) and the precision of the first extraction round for wheat seeds (27.5% CV). Since the concentration of HPPD in the sample analysis was determined from a single extraction (first round) and can be adjusted for the extraction efficiency %, and since a precision of 20.0% or less was achieved for wheat seeds in the precision and accuracy run, there is no impact on the results of the study. Based on the results of this study, it was confirmed that the mass spectrometry-based method is suitable for the quantification of HPPD protein in agricultural crops according to the GLPS.
[0065] The objective of this study was to validate a mass spectrometry (MS)-based method for quantifying p-hydroxyphenylpyruvate dioxygenase (HPPD) protein in various agricultural crops (barley, corn, rice, soybean, and wheat seeds, and barley, corn, oat, soybean, and wheat forage) using liquid chromatography coupled to tandem mass spectrometry (LC-MS / MS) analysis. Surrogate peptides specific to the HPPD protein were used to determine the relative concentrations in various plant species / matrices (Table 3). Prior to implementing the quantitative method in the study, the method was validated for the intended application in accordance with Good Laboratory Practice Standards (GLPS). Crop samples were used to evaluate the method performance parameters, including specificity, linearity, limit of quantification, carryover, precision and accuracy, extraction efficiency, and stability.
[0066] [Table 3]
[0067] The crop materials for this study were matrices from various plant species and were used to prepare linearity and quality control (QC) samples. Table 4 identifies the source of matrix materials. These samples were provided by the sponsor and stored at a nominal temperature of -80°C ± 10°C until use.
[0068] [Table 4]
[0069] Standards and QC samples For linearity assessment, a reverse curve was generated. A series of eight non-zero standards (STDs) were prepared using crop extracts enriched with SIL peptides at various concentrations, including both the LLOQ (STD1) and ULOQ (STD8) STDs.
[0070] QC samples were prepared using crop extracts enriched with unlabeled peptides at three different concentrations (low, medium and high). Tables 5 and 6 show the nominal concentrations.
[0071] [Table 5]
[0072] [Table 6]
[0073] Synthetic Peptides The purified and quantified SIL and unlabeled synthetic peptides used in this study are listed in Table 7. Synthetic peptides were supplied by JPT Peptide Technologies GmbH and stored at a nominal temperature of -20°C until use.
[0074] [Table 7]
[0075] Analysis method The following experimental and data evaluation steps were involved in the validation process of the LC-MS / MS based method for determining the amount of HPPD protein in crops. Briefly, the LC-MS / MS method for identifying and quantifying surrogate peptides of HPPD in complex biological matrices includes: (i) weighing the lyophilized crops; (ii) homogenizing / extracting proteins from the plant species / matrix samples in lysis buffer; (iii) centrifuging the samples to separate soluble and insoluble proteins to enrich the protein of interest and reduce the complexity of the sample; (iv) digesting the soluble protein samples with trypsin; (v) centrifuging the samples; (vi) adding SIL peptides (fixed or variable depending on the evaluation); (vii) desalting by solid phase extraction using cation exchange to minimize matrix effects or interferences and reduce ion suppression; and (viii) analyzing the samples by LC-MS / MS. The surrogate peptides of interest and the corresponding SIL peptides that are unique to the HPPD protein for each crop were measured by LC-MS / MS. Data were analyzed using MultiQuant™ software, version 3.0.2, and the chromatographic peak areas of each surrogate peptide (unlabeled) and each corresponding SIL peptide were integrated for each sample.
[0076] For the reverse curves, the peak area of the SIL peptide was determined for each surrogate peptide.The peak area of the SIL peptide for each standard sample was then plotted on the y-axis as a function of protein concentration (x-axis) for each surrogate peptide to generate a reverse curve.
[0077] For the QC samples, the peak area ratio (peak area of unlabeled peptide / peak area of corresponding SIL peptide) was determined. The unlabeled peptide concentration of the QC samples was calculated as follows:
number
[0078] Sample Processing Between 10 mg and 18 mg of each crop was weighed and added to a tube containing Matrix A lysis beads (MP Biomedicals). Lysis buffer (0.1% RapiGest™ (Waters) in phosphate buffered saline (PBS)) was then added to each sample tube and homogenized using a FastPrep®-24 Homogenizer (MP Biomedicals). Samples were then centrifuged at 4° C. to remove insoluble material. Supernatants were decanted, pooled, and appropriately diluted in 0.1% RapiGest in PBS as described in Table 8. These diluted crops were fortified with either SIL peptide (to provide standards) or various concentrations of unlabeled peptide (to provide QC samples).
[0079] [Table 8]
[0080] For each of the processed standards and QC samples, the proteins were denatured by adding an equal volume of 2,2,2-trifluoroethanol (TFE), then diluted to 10% in TFE containing 100 mM ammonium bicarbonate and digested with 0.1 μg / μL trypsin by incubation at 37 °C for 14–18 h. After digestion, samples were acidified with a final formic acid (FA) concentration of 5%, and SIL peptides were added to each sample at variable or fixed concentrations depending on the validation evaluation, except for blanks and carryover blanks. Samples were then desalted by solid-phase extraction using a mixed-mode cation exchange (MCX) μElution plate. The eluent was collected and transferred to two MS plates, which were evaporated to dryness and stored at -20 °C (nominal) until MS analysis.
[0081] Processed samples were resolubilized with 11 μL of 92.5 / 7.5 water / acetonitrile (ACN) + 0.2% FA, followed by sonication, vortexing, and centrifugation. Eight microliters of material per sample was injected into a NanoAcquity Ultra Performance Liquid Chromatography (UPLC)® (Waters) coupled to a QTRAP 6500 mass spectrometer (AB Sciex). Separation of peptides was achieved using a HALO peptide ES-C18 50mmx0.5mm, 2.7μm column (Canadian Life Science). The LC gradient used is shown in Table 9 below. The flow rate was 28.000 μL / min. Analytes were measured in positive ion mode using a Turbo V MS source. Data collection was performed using Analyst® version 1.6 (AB Sciex).
[0082] [Table 9]
[0083] The surrogate peptides and the corresponding SIL peptides are unique to the HPPD protein. The chromatographic peak areas of each surrogate peptide (unlabeled) and each corresponding SIL peptide were integrated for each sample using MultiQuant version 3.0.2 (AB Sciex).
[0084] For the reverse curves, the peak area of the SIL peptide was determined for each surrogate peptide. The peak area of the SIL peptide for each standard sample was plotted on the y-axis as a function of protein concentration (x-axis) to generate the reverse curves.
[0085] For the QC samples, the peak area ratio (peak area of unlabeled peptide / peak area of the corresponding SIL peptide) was determined. The unlabeled peptide concentrations of the QC samples were calculated as above.
[0086] Calculations of mean, standard deviation (SD), and coefficient of variation (CV) were performed using Microsoft Office Excel® software. Unrounded values were used in the calculation of mean, SD, and CV, and rounded appropriately in summary tables.
[0087] specificity Specificity is determined by the ability of the method to measure and distinguish between surrogate peptides in the presence of various plant matrix components in the sample. Specificity is measured by determining the presence or absence of each surrogate peptide unique to the HPPD protein by LC-MS / MS.
[0088] The specificity of the assay was assessed in all crop extracts using quantifier and qualifier transitions for unlabeled peptides and only quantifier transitions for SIL peptides as described below.
[0089] Unlabeled peptides The following analyses were performed: The specificity of the assay was evaluated by comparing the mean ratio (n=3) of the two transitions (quantitative / confirmatory) monitored in digested bovine serum albumin (BSA) buffer fortified with unlabeled peptide to a blank (n=3), which was considered a matrix with detectable amounts of endogenous HPPD protein processed without the addition of SIL or unlabeled peptide.
[0090] The % difference was calculated using the following formula:
number
[0091] The following acceptance criteria were used to confirm the suitability of the unlabeled peptides for specificity assessment: the % difference between blank and buffer must be within 30.0%.
[0092] SIL Peptides The following analyses were performed: The specificity of the assay was evaluated by determining the peak area of the SIL peptide (quantitative transition) in QC0 (endogenous, n=3) versus a blank (n=3), which is considered a matrix with detectable amounts of endogenous HPPD protein processed without the addition of SIL or unlabeled peptide.
[0093] The % of QC0 (intrinsic) was calculated using the following formula:
number
[0094] The following acceptance criteria were used to confirm suitability of the SIL peptide specificity assessment: the average SIL peptide peak area in the blank sample must be 5.0% or less of the average peak area of the SIL peptide in the QC0 (endogenous) sample.
[0095] linearity Linearity is the ability of a method to produce results that are mathematically defined by the amount of analyte in the sample and the response. Linearity was assessed based on the accuracy of the method. For HPPD in each plant species / matrix, the simplest regression model was used to define the reverse curve, i.e., a linear curve fit. The correlation coefficient (R value) was used to apply the model based on the quality of the fit.
[0096] A data weighting of 1 / x was applied to all peptides. The same regression model and the same data weighting were applied to all assay runs for each plant species / matrix.
[0097] The following run acceptance criteria were used to confirm suitability of the linearity assessment: (1) at least 75.0% of the non-zero standards must be valid and must not deviate by more than 20.0% of the nominal concentration, except for the LLOQ, in which case the deviation must not exceed 25.0%; (2) the interpolated curve must have an R ≥ 0.9900.
[0098] Limit of quantification The LLOQ and ULOQ are the minimum and maximum concentrations at which the response of the surrogate peptide can be determined within an acceptable range of accuracy. The LLOQ and ULOQ were determined for the surrogate peptide in each plant species / matrix using reverse curves as described.
[0099] The following acceptance criteria were used to confirm suitability for the LLOQ and ULOQ assessments: The LLOQ and ULOQ standards must meet the accuracy criteria defined above.
[0100] The quantitative range of HPPD is the interval between the upper and lower concentration limits where the analytical procedure was demonstrated to have an adequate level of accuracy and linearity (see Table 5 for standards concentrations). Data obtained from the linearity evaluation of the method were used to determine the quantitative range for HPPD in each plant species / matrix. Effective accuracy determinations validated the high and low concentrations tested as the quantitative range of the procedure.
[0101] Carryover is when the analyte is present in subsequent injections. In this study, carryover is determined during linearity evaluation by evaluating two blank samples injected after each ULOQ standard. These must not be subject to interference. For all linearity runs, the following run acceptance criteria were applied to evaluate carryover: The first carryover blank sample injected after the ULOQ standard was evaluated. The second carryover blank was evaluated but was not part of the acceptance criteria. At least 50% of the first carryover blank sample injected after the ULOQ standard must be within the acceptable interference range described below at the retention time of the SIL peptide: the peak area must be 20.0% or less of the average peak area of the SIL peptide of the LLOQ standard. Additionally, in precision and accuracy as well as stability evaluations, resolubilization buffer (RSB) samples were analyzed to evaluate carryover after injection of high QC samples. The sequence to evaluate carryover was high QC followed by two RSB samples.
[0102] Run Acceptance Criteria As part of the validation, precision and accuracy and stability runs included QC samples to demonstrate the acceptance of the run. For the above run to be considered valid, the following criteria must be met: Each plant species / matrix was independently tested against the acceptance criteria.
[0103] QC Samples QC samples provide the basis for the acceptance or rejection of a run. QC samples are prepared by fortifying the sample matrix with known concentrations of unlabeled peptide. The following acceptance criteria were used to confirm the suitability of the QC samples using low QC (QC1), medium QC (QC2), and high QC (QC3): (1) at least 50% of the QC samples at each concentration (low, medium, and high) must be within ±20.0% bias; (2) at least 67% of the QC samples across low, medium, and high concentrations must be within ±20.0% bias of their nominal value.
[0104] Precision and accuracy Precision is the degree of agreement between individual test results when a procedure is applied repeatedly to multiple samplings of the same kind of sample. Accuracy is the degree of agreement between an actual value and an accepted reference value when a procedure is applied repeatedly to multiple samplings of the same kind of sample. In this study, the precision and accuracy of the LC-MS / MS assay for HPPD protein in each plant species / matrix was determined by assessing the inter-assay and inter-analyst variability.
[0105] The precision and accuracy of the method was evaluated using QC samples. Precision and accuracy assays were performed using three concentrations (low, medium and high) of QC samples (Tables 5 and 6). The QC samples were prepared in crop extracts and fortified with unlabeled peptides.
[0106] Precision (CV) and accuracy (bias) were assessed across three independent assay runs by two different analysts on three separate days.
[0107] Each precision and accuracy run consisted of three replicates for each QC concentration. QC0 (endogenous) was also included and analyzed in triplicate.
[0108] The % bias was calculated using the following formula:
number
[0109] Intra-assay precision and accuracy were assessed using precision and accuracy runs that met the run acceptance criteria described in Section 0. Inter-assay precision and accuracy were then assessed using precision and accuracy runs that met the intra-assay criteria. The following acceptance criteria were used to confirm suitability of the intra-assay and inter-assay run precision and accuracy assessments: (1) the CV for QC0 samples must be ≤ 25.0%; (2) the CV for low, mid, and high level QC samples must be ≤ 20.0% and within ±20.0% bias.
[0110] In addition, a maximum length of injection time of the assay run for research sample analysis was established by looking at the batch size of the precision and accuracy runs. The precision and accuracy runs with the maximum batch size were used to set the maximum length of injection time for research sample analysis. Additionally, a trend analysis of the QC0 (endogenous) samples was performed.
[0111] Extraction efficiency is the amount of protein of interest (i.e., HPPD) recovered from the matrix. Extraction efficiency was determined by successive sequential extractions. Extraction recovery was considered final if 5.0% or less of the total protein was recovered in the last round. The efficiency of the protein extraction method was evaluated with crop plants through repeated extractions of HPPD.
[0112] One analyst extracted three replicates of each crop. The insoluble material was collected and extracted a further three times, with each supernatant retained for analysis.
[0113] The extraction efficiency of each sample was calculated using the following formula:
number
[0114] The following acceptance criteria were used to confirm the adequacy of extraction efficiency for each protein: sequential extractions would be considered complete if the final extraction results were 5.0% or less of the total material recovered for each individual protein from all combined extracts:
number
[0115] Extraction efficiency (average of replicates from the first iteration) is expected to be 60.0% or greater recovery, and precision for the first extraction round should be 20.0% or less.
[0116] stability The stability of HPPD protein in a given plant species / matrix was evaluated over a given time interval under specific conditions. The stability of HPPD protein in each plant species / matrix was determined for surrogate peptides in the processed samples.
[0117] Stability of processed samples Processed sample stability of dried extracts at two different concentrations (low and high) with three replicates per concentration was analyzed. Freshly prepared and processed QC samples were analyzed by LC-MS / MS (considered Day 0). Dried stability samples were not immediately analyzed by LC-MS / MS but were stored for a given time.
[0118] Dried stability samples were stored at a nominal temperature of -20°C for 6 days (146 hours 16 minutes) before being resolubilized and analyzed by LC-MS / MS.
[0119] The following acceptance criteria were used to confirm the stability of the surrogate peptides in the processed samples: (1) the overall average peak area ratio of the processed Day 0 and stability samples must be less than or equal to 25.0% CV; (2) the percentage difference in peak area ratio between stability QC and Day 0 QC (processed on the same injection day) must be within ±25.0%.
number
[0120] Although the validation protocol properly outlines the carryover assessment in the general description and clearly states that peak area is used for carryover assessment, erroneously, the description found in the acceptance criteria specifies peak area ratio. Peak area is the correct way to perform the assessment, and therefore, peak area was used to evaluate interference in this study. Therefore, there is no impact on the quality and completeness of the data, as the proper approach (i.e., peak area) was applied to evaluate interference in the carryover blank.
[0121] The validation protocol uses the peak area ratio (SIL / unlabeled) of each peptide of the quantitative transition to plot the calibration curve data on a linear scale. However, we used the peak area of each peptide of the quantitative transition instead for plotting. The peak area ratio cannot be used for linearity assessment due to the contribution to the unlabeled signal from the high spiking concentration of stable isotope-labeled peptide. The linearity assessment was performed so that there is no impact on the quality and integrity of the data.
[0122] According to the validation protocol, extraction efficiency evaluation is performed using four sequential extractions (rounds). For two matrices (i.e., barley and wheat seeds), the extraction efficiency results did not meet the acceptance criteria as outlined below. Barley seeds - final extraction (fourth round) result was 8.2% (acceptance criteria: <5.0%). Wheat seeds - final extraction (fourth round) result was 6.2% (acceptance criteria: <5.0%). The precision of the first extraction round was 27.5% CV (acceptance criterion: ≦20.0%).
[0123] However, there is no impact on the results of the study because: (1) the final extraction results of barley and wheat seeds indicate that the extraction of HPPD protein is nearly complete after four extraction rounds. Furthermore, the concentration of HPPD in the sample analysis is determined from a single extraction (first round) and can be adjusted according to the extraction efficiency %; and (2) for wheat seeds, although the precision of the first extraction round (27.5% CV) exceeds the 20.0% CV criterion, the QC0 (intrinsic) precision and accuracy results from three validation runs (runs 4-6) obtained from single extractions demonstrate that a precision of 20.0% or less was achieved.
[0124] The validation protocol ensures that for each precision and accuracy run, at the end of each matrix, two RSB samples are injected after the high QC sample. However, for one matrix (i.e., wheat seeds), the RSB sample injected after the high QC sample (QC3, replicate 3) was mistakenly acquired using the MRM method for peptide GNFSQLFK (SEQ ID NO:2) instead of peptide GNFSELFK (SEQ ID NO:1). Therefore, RSB carryover assessment was not performed for wheat seeds.
[0125] However, there is no impact on the results of the study, since: (1) no carryover of peptide GNFSELFK (SEQ ID NO: 1) was observed for any of the other matrices (including wheat feed), and therefore, as a relative conclusion, it can be inferred that peptide GNFSELFK (SEQ ID NO: 1) does not show any tendency for carryover, and the carryover possibility of peptide GNFSELFK in wheat seed matrix is very low; and (2) as a result, the available data set allows the establishment of RSB carryover acceptance criteria (i.e., unlabeled peptide peak area at RT vs. QC0 peak area ≦5.0%) for peptides GNFSELFK (SEQ ID NO: 1) and GNFSQLFK (SEQ ID NO: 2) to be used in the analysis of samples in all matrices (including wheat seed).
[0126] There were also minor SOP deviations that did not affect the study. These were recorded in the study files. No other circumstances occurred during the conduct of this study that could have adversely affected the quality or integrity of the data generated.
[0127] specificity The specificity of the assay was evaluated for unlabeled and SIL peptides in all crop extracts. The evaluation showed some minor interferences with the retention times of the surrogate peptides and the corresponding SIL peptides in the crop samples tested. For unlabeled peptides, the percentage difference in the mean ratio of the two transitions between blank and buffer samples was lower than 30.0% in all plant species / matrices tested, and all interferences were less than 5.0% of the mean peak area of the SIL peptides in the QC0 (endogenous) samples, meeting the specificity acceptance criteria.
[0128] linearity Linearity was determined for HPPD protein in each plant species / matrix using the reverse curves described in Sections 3.4 and 0. The simplest regression model to define the reverse curves was used, i.e., linear regression. A data weighting of 1 / x was used for all plant species / matrices. Table 10 summarizes the standard curve parameters (slope, intercept and R value) for linearity assessment. The correlation coefficients (R) of the standard curves for HPPD protein in each plant species / matrix were 0.9900 or greater. All established data fell within the acceptance criteria described in Section 0 and were found to be suitable for linearity assessment.
[0129] [Table 10]
[0130] The reverse curve standard concentrations calculated inversely for each plant species / matrix are provided in Table 11.
[0131] [Table 11]
[0132] Limit of quantification In the linearity assessment, the accuracy (bias) was within ±25.0% and ±20.0% for the LLOQ and ULOQ samples, respectively (Table 11), therefore the quantification limits were set at the lowest and highest non-zero standard concentrations. Table 12 summarizes the lower and upper limits of quantification for HPPD in each plant species / matrix.
[0133] [Table 12]
[0134] The quantitative range of HPPD in each plant species / matrix is the interval between the lower limit (LLOQ) and upper limit (ULOQ) concentrations at which the analytical procedure was demonstrated to have an adequate level of accuracy. The LLOQ and ULOQ samples met the accuracy criteria for HPPD in each plant species / matrix. The quantitative range of the method was established for each plant species / matrix (Table 13).
[0135] [Table 13]
[0136] Carryover Carryover was determined in the linearity evaluation by evaluating blank samples injected after the ULOQ standard for the crop samples tested. The evaluation showed no interference with the retention times of the SIL peptides. In at least 50% of the first carryover blank samples injected after the ULOQ standard, the SIL peptide peak area ratio was 20.0% or less of the average peak area ratio of the SIL peptides of the LLOQ standard, meeting the carryover acceptance criteria.
[0137] Additionally, carryover was evaluated during precision and accuracy as well as stability runs using RSB samples after injection of high QC samples. Overall, the evaluation showed no carryover in the blank samples. The RSB blank carryover acceptance criteria for study sample analysis will be 5.0% or less of the average peak area of unlabeled peptides in the QC0 (endogenous) sample.
[0138] Precision and accuracy The QC samples described herein were used to evaluate the precision and accuracy of the HPPD method for agricultural crops. There were three precision and accuracy runs. All met the run acceptance criteria. Precision (CV) and accuracy (bias) data for the intra- and inter-assay runs are summarized in Tables 14-23 (one table per plant species / matrix).
[0139] For both intra- and inter-assay, the CVs were less than 25.0% for QC0 samples and less than 20.0% for low, medium and high QC samples, therefore the method precision assessment was adequate.
[0140] For both intra- and inter-assay, bias was within the range of ±20.0% for low, medium and high QC samples and therefore the method precision assessment was adequate.
[0141] The longest injection time for a precision and accuracy batch was approximately 36 hours 58 minutes (batch size of 187 injections), and therefore this was established as the maximum length of injection time for the assay for research sample analysis.
[0142] Trend analyses were performed on QC0 (intrinsic) samples from precision and accuracy runs. Sample run QC0 (intrinsic) samples were also analyzed to extend the trend analysis.
[0143] [Table 14]
[0144]
Table 15
[0145]
Table 16
[0146]
Table 17
[0147]
Table 18
[0148]
Table 19
[0149]
Table 20
[0150]
Table 21
[0151]
Table 22
[0152]
Table 23
[0153] Extraction efficiency Table 24 summarizes the efficiency of the protein extraction method from crops. All plant species / matrices for HPPD reached acceptable extraction efficiency in a single repeat. The average extraction efficiency of HPPD from barley seeds (59.9%), corn seeds (69.8%), rice seeds (73.9%), soybean seeds (64.9%), wheat seeds (54.3%), barley feed (69.8%), corn feed (76.3%), oat feed (78.4%), soybean feed (65.4%) and wheat feed (77.2%) demonstrates that the method meets the acceptable extraction efficiency evaluation. Furthermore, the CV values were lower than 20.0% for HPPD in all plant species / matrices and the amount in the final extraction was lower than 5.0% for all crops except barley and wheat seeds.
[0154] [Table 24]
[0155] Table 25 summarizes the stability of dried extracts of surrogate peptides over 6 days (146 hours 16 minutes) at a nominal temperature of -20° C. For stability evaluation of dried processed samples, the average peak response ratios of the stability samples were below 25.0% CV and the % difference of the stability samples compared to the Day 0 QC samples was within ±25.0%.
[0156] [Table 25]
[0157] The objective of this study was to validate an MS-based method for quantifying p-hydroxyphenylpyruvate dioxygenase (HPPD) protein in various agricultural crops (barley, corn, rice, soybean, and wheat seeds, and barley, corn, oat, soybean, and wheat forage) using LC-MS / MS. Relative concentrations were determined using surrogate peptides unique to the HPPD protein. Crop samples were used to evaluate method performance parameters, including specificity, linearity, limit of quantification, carryover, precision and accuracy, extraction efficiency, and stability.
[0158] The specificity assessment showed no significant interference with the retention times of unlabeled peptides (mean ratio of the two transitions differed less than 30.0% between blank and buffer) and SIL peptides (5.0% or less of the SIL signal of QC0 (endogenous)) in any of the crop samples tested. All specificity parameters met the acceptance criteria.
[0159] The lower limit of quantification and the quantitative range (fmol / mgDW and μg / gDW) for HPPD in crops are shown in Table 26.
[0160] [Table 26]
[0161] The intra- and inter-assay precision and accuracy of the method are summarized in Table 27.
[0162] [Table 27]
[0163] A first-order equation was determined to adequately describe the concentration / detector response relationship for HPPD in all crops. A data weighting of 1 / x was used for all crops.
[0164] The efficiency of the protein extraction method was 59.9% for barley seeds, 69.8% for corn seeds, 73.9% for rice seeds, 64.9% for soybean seeds, 54.3% for wheat seeds, 69.8% for barley feed, 76.3% for corn feed, 78.4% for oat feed, 65.4% for soybean feed, and 77.2% for wheat feed. The CV of the first extraction round was lower than 20.0% for all crops except wheat seeds, which had a CV of 27.5%. However, the precision and accuracy results of QC0 (intrinsic) for wheat seeds from a single extraction demonstrate that an accuracy of 20.0% or less was achieved.
[0165] Processing stability (dried extract) was evaluated for 6 days at -20°C. The stability evaluation met the acceptance criteria. The CV was less than or equal to 25.0% and the % difference in peak area ratio between stability QC and Day 0 QC was within ±25.0% for all crops.
[0166] All performance parameters evaluated met the defined acceptance criteria, except for the final extraction % for barley and wheat seeds (8.2 and 6.2%, respectively) and the precision of the first extraction round for wheat seeds (27.5% CV). Since the concentration of HPPD in the sample analysis was determined from a single extraction (first round) and can be adjusted for the extraction efficiency %, and since a precision of 20.0% or less was achieved for wheat seeds in the precision and accuracy run, there is no impact on the results of the study. Based on the results of this study, the mass spectrometry-based method was confirmed to be suitable for the quantification of HPPD protein for the list of crops evaluated in this study according to the GLPS.
[0167] Although the invention has been described with respect to specific embodiments thereof, it will be understood that the device of the invention is capable of further modification. This patent application is intended to cover any variations, uses, or adaptations of the invention which generally follow the principles of the invention and which come within known or customary practice within the art to which the invention pertains, and which may be applied to the essential features set forth herein above, including such departures from the present disclosure as fall within the scope of the appended claims.
[0168] All publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Claims
1. 1. A labeled surrogate peptide that functions to selectively detect or quantify p-hydroxyphenylpyruvate dioxygenase (HPPD) protein in a mixture of proteins in one or more biological samples from one or more crop plants in a mass spectrometry assay, said surrogate peptide comprising a label and an amino acid sequence selected from the group consisting of GNFSELFK (SEQ ID NO:1) and GNFSQLFK (SEQ ID NO:2).
2. The labeled surrogate peptide of claim 1 , wherein the peptide is labeled by incorporation of a stable isotope labeled (SIL) amino acid.
3. 3. The labeled surrogate peptide of claim 2, wherein the SIL amino acid is lysine, isoleucine, valine, or arginine.
4. The labeled surrogate peptide of claim 1 , wherein the plant is barley, rice, soybean, wheat, oat or corn.
5. The surrogate peptide of claim 4, wherein the plant is barley, soybean, wheat or rice, and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:
1.
6. The surrogate peptide of claim 4, wherein the plant is maize and the surrogate peptide comprises a label and the amino acid sequence of SEQ ID NO:
2. (i) a first synthetic labeled surrogate peptide comprising a label and consisting of the amino acid sequence of SEQ ID NO:1; (ii) a second synthetic, labeled surrogate peptide comprising a label and consisting of the amino acid sequence of SEQ ID NO:
2.
8. 1. A method for simultaneously detecting or quantifying one or more target p-hydroxyphenylpyruvate dioxygenase (HPPD) proteins in a complex biological sample from a crop plant containing a mixture of target and non-target proteins, comprising: a. obtaining a biological sample from a crop plant; b. extracting proteins from said biological sample to result in an extract comprising a mixture of proteins; c. reducing the amount of insoluble protein in the extract of step b, resulting in an extract of enriched soluble protein; d. digesting the soluble proteins in the extract of step c to result in an extract containing peptide fragments, the peptide fragments comprising at least one unlabeled surrogate peptide specific for one or more target HPPD proteins; e. concentrating the peptide fragments in the extract of step d; f. adding one or more synthetic labeled surrogate peptides comprising a label and the amino acid sequence of SEQ ID NO:1 or SEQ ID NO:2, wherein each synthetic labeled surrogate peptide in the mixture is an analog of an unlabeled surrogate peptide of a target HPPD protein and has the same amino acid sequence as the unlabeled surrogate peptide of said target protein, and the number of labeled surrogate peptides added is equal to the number of target proteins in the mixture; g. enriching the unlabeled surrogate peptides and the synthetic labeled surrogate peptides by reducing the amount of non-surrogate peptides in the mixture; h. Separating the peptide fragment mixture from step g by liquid chromatography; i. analyzing the peptide fragment mixture obtained from step h by mass spectrometry, wherein detection of transition ion fragments of the synthetic labeled surrogate peptide indicates the presence of the target protein from which the unlabeled surrogate peptide is derived; and optionally, j. calculating the amount of target protein in said biological sample by comparing the mass spectrometry signals generated from the transition ion fragments of step i with the mass spectrometry signals generated by the transitions; The method includes:
9. 9. The method of claim 8, wherein the crop plant is barley, soybean, wheat or rice and the synthetic labeled surrogate peptide comprises the amino acid sequence of SEQ ID NO:
1.
10. 9. The method of claim 8, wherein the crop plant is maize and the synthetic labeled surrogate peptide comprises the amino acid sequence of SEQ ID NO:
2.
11. The method of claim 9 or 10, wherein the synthetic labeled surrogate peptide is labeled by incorporation of a stable isotope labeled (SIL) amino acid.
12. 12. The method of claim 11, wherein the SIL amino acid is lysine, isoleucine, valine, or arginine.
Citation Information
Patent Citations
Quantitative analysis of transgenic proteins
JP2017519206A
Methods of determining plant zygosity using mass spectrometry
US20120080590A1
Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
US20140053295A1
Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (HPPD) activity
US20170058291A1
